Peterka Insurance Marketing
  • Home
  • Seminars
  • Medicare
    • Medicare Supplement Coverage
    • Medicare Advantage Plans
    • Prescription Drug Plans
    • Helpful Links
    • Medicare Consultation
  • Life & Health
    • Life >
      • Life Insurance
      • Health Insurance
    • Health >
      • Critical Illness Insurance
      • Dental Insurance
      • Group Benefits
      • Long Term Care Insurance
      • Travel Insurance
  • Quotes
    • Medicare Quotes >
      • Medicare Supplement Coverage Quote
      • Medicare Advantage Plan Quote
      • Prescription Drug Plans Quote
    • Health Quotes >
      • Health Insurance Quote
      • Critical Illness Insurance Quote
      • Dental Insurance Quote
      • Final Expense Insurance
      • Group Benefits Insurance Quote
      • Long Term Care Insurance Quote
      • Travel Insurance Quote
    • Life Quotes >
      • Life Insurance Quote
      • Final Expense Insurance Quote
  • Resources
    • Online Documents
    • Prescription Drug Analysis
    • Update Contact Info
  • About
    • Meet Our Team
    • Client Testimonials
    • Insurance Carriers
    • Agency Photo Gallery
    • Accessibility Statement
  • Contact
  • Blog

Blog

Medicare Officially Limits Coverage of Aduhelm
​to Patients in Clinical Trials

New York Times - August 8, 2022
Picture
Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.

Ever since Medicare proposed to sharply limit coverage of the controversial Alzheimer’s drug Aduhelm, the agency has been deluged with impassioned pleas.

Groups representing patients insisted the federal insurance program pay for the drug. Many Alzheimer’s experts and doctors cautioned against broadly covering a treatment that has uncertain benefit and serious safety risks.

On Thursday, Medicare officials announced their final decision. Though the Food and Drug Administration has approved Aduhelm for some 1.5 million people, Medicare will cover it only for people who receive it as participants in a clinical trial.

Chiquita Brooks-LaSure, the administrator of the Centers for Medicare and Medicaid Services, or CMS, said the decision was intended to protect patients while gathering data to indicate whether Aduhelm, an expensive monoclonal antibody given as a monthly infusion, could actually help them by slowing the pace of their cognitive decline.
BACK TO BLOG PAGE
Licensed in  Arizona, California, Florida, Hawaii, Idaho, Illinois, Nevada, New York, Oregon, South Dakota, Texas, Utah, and Washington.
We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area.
​Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options.

Navigation

Homepage
Seminars
Medicare
Life and Health
Policy Service
Contact Us
Agent Login

Contact Us

Peterka Insurance Marketing
CA License # 0L60382
1451 Quail Street, Suite 109
Newport Beach, CA 92660
(714) 289-1099
Click Here to Email Us

Location

Image credit: Newport Beach by Pumaphotog (CC BY-SA 4.0)  |  Website by InsuranceSplash
  • Home
  • Seminars
  • Medicare
    • Medicare Supplement Coverage
    • Medicare Advantage Plans
    • Prescription Drug Plans
    • Helpful Links
    • Medicare Consultation
  • Life & Health
    • Life >
      • Life Insurance
      • Health Insurance
    • Health >
      • Critical Illness Insurance
      • Dental Insurance
      • Group Benefits
      • Long Term Care Insurance
      • Travel Insurance
  • Quotes
    • Medicare Quotes >
      • Medicare Supplement Coverage Quote
      • Medicare Advantage Plan Quote
      • Prescription Drug Plans Quote
    • Health Quotes >
      • Health Insurance Quote
      • Critical Illness Insurance Quote
      • Dental Insurance Quote
      • Final Expense Insurance
      • Group Benefits Insurance Quote
      • Long Term Care Insurance Quote
      • Travel Insurance Quote
    • Life Quotes >
      • Life Insurance Quote
      • Final Expense Insurance Quote
  • Resources
    • Online Documents
    • Prescription Drug Analysis
    • Update Contact Info
  • About
    • Meet Our Team
    • Client Testimonials
    • Insurance Carriers
    • Agency Photo Gallery
    • Accessibility Statement
  • Contact
  • Blog